Global Scopolamine Market Is Estimated To Witness High Growth Owing To Growing Demand for Motion Sickness Medications
The global Scopolamine market is estimated to be valued at US$ 462.7 million in 2022 and is expected to exhibit a CAGR of 4.8% over the forecast period, as highlighted in a new report published by Coherent Market Insights.A) Market Overview: Scopolamine is a medication used to prevent nausea and vomiting caused by motion sickness or post-operative conditions. It works by blocking certain...
0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
Спонсоры